Pfizer News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

18.12.13	Mylan Acquires Rights To Novel LAMA Respiratory Compound From Pfizer (RTTNews)
17.12.13	Pfizer Resolves Patent Litigation Against Teva - Quick Facts (RTTNews)
17.12.13	Pfizer Makes Several Senior Executive Appointments - Quick Facts (RTTNews)
16.12.13	Siemens Healthcare Reaches Master Deal With Pfizer For Companion Diagnostics (RTTNews)
12.12.13	Lpath Withdraws From Pfizer' Process To Assign ISONEP Rights (RTTNews)
02.12.13	Pfizer's Unit Buys Polocard, A Low-dose Aspirin - Quick Facts (RTTNews)
02.12.13	Pfizer Acquires Polocard, Poland’s Leading Over-The-Counter Heart Attack Prevention Brand (Businesswire)
22.11.13	ViiV Healthcare: Tivicay Gets Positive CHMP Opinion In Europe To Treat HIV (RTTNews)
21.11.13	Pfizer, GSK To Collaborate For Phase I/II Study With Palbociclib & Trametinib (RTTNews)
18.11.13	Pfizer Receives FDA Approval For XELJANZ - Quick Facts (RTTNews)
08.11.13	Pfizer: Rapamune Phase 3B/4 Study Fails To Meet Primary Endpoint - Quick Facts (RTTNews)
05.11.13	Pfizer Says FDA Okays Prior Approval Supplement For EMBEDA ER Capsules CII (RTTNews)
29.10.13	Pfizer Q3 Profit Falls, Cancer Drugs Post Double-digit Revenue Growth (RTTNews)
29.10.13	Pre-market Movers For Oct 29 (AAPL, NOK, PFE, VOLC, STX) (RTTNews)
29.10.13	Pfizer Q3 Profit Down; Updates FY13 Outlook - Quick Facts (RTTNews)
29.10.13	Earnings Watch For October 29 (PFE, BIDU, DWA, LNKD, EA) (RTTNews)
23.10.13	EPZM, MDVN On Watch, MYGN In Legal Spat With BRLI, ONVO's 3D Story Gets Better (RTTNews)
22.10.13	ViiV Healthcare announces US regulatory submission for a single-tablet regimen combining dolutegravir with abacavir and lamivudine for people living with HIV (PR Newswire)
22.10.13	DURECT Says Pfizer Will Continue Development Program For REMOXY (RTTNews)
22.10.13	Pfizer Proceeding with REMOXY® Development (PR Newswire)
22.10.13	Stock Price Movements, Clinical Study Results, and New Appointments - Research Report on Pfizer, Gilead Sciences, Amgen, Celgene, and Insys Therapeutics (PR Newswire)
21.10.13	Innovative Biotechs Making Strides In Healthcare Sector: Alliqua, MiMedx, Organovo, Anacor Pharmaceuticals, Pfizer (PR Newswire)
18.10.13	Pfizer Reports Results From Two Lyrica Capsules CV Phase 3b Studies (RTTNews)
17.10.13	Pfizer Gets European Approval For Label Update Regarding Use Of Prevenar 13 (RTTNews)
14.10.13	Clinical Trial Results, Conference Calls, and Acquisitions - Research Report on Pfizer, UnitedHealth, Actavis, Bristol-Myers Squibb, and Quest Diagnostics (PR Newswire)
09.10.13	Pfizer Reports Top-line Results From Tofacitinib Phase 3 Trials - Quick Facts (RTTNews)
09.10.13	FDA Approvals, Completed Tender Offers, Hospital Ratings, Trial Study Results, and Stock Price Movements - Research Report on Pfizer, Amgen, Cigna, Hologic, and Insys Therapeutics (PR Newswire)
07.10.13	Critical Alerts For Pfizer, Universal Display, Royal Gold, Las Vegas Sands, and NVIDIA Released By InvestorsObserver (PR Newswire)
04.10.13	Under AAAResearchReports.com Microscope: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. (PR Newswire)
03.10.13	Pfizer Announces FDA Approval For DUAVEE Therapy - Quick Facts (RTTNews)
02.10.13	Regulatory Approval, New Appointments, Stock Price Movements, and Other Announcements - Research Report on Pfizer, Warner Chilcott, Rockwell Medical, InterMune, and Ligand (PR Newswire)
01.10.13	Pharmaceutical Companies Announce Trial Results, and Achieve New Contracts, Regulatory Approvals, and Positive Opinion - Research Report on Eli Lilly, Pfizer, Novartis, Sanofi, and AstraZeneca (PR Newswire)
30.09.13	Presentation, Licensing Agreement, Trial Milestone, Positive Opinion, and Trade Name Acceptance - Research Report on Pfizer, Allergan, Novartis, AstraZeneca, and Rockwell Medical (PR Newswire)
30.09.13	Bayer Appoints Olivier Brandicourt As CEO Of HealthCare Unit - Quick Facts (RTTNews)
24.09.13	Stock Movements, Quarterly Dividends and Product Recall News - Research Report on Pfizer, Johnson & Johnson, Bristol-Myers, Merck, and Abbvie (PR Newswire)
20.09.13	Issuer Ratings, Recognitions, Positive Clinical Results, and Quarterly Dividends - Research Report on Pfizer, UnitedHealth, Merck, Gilead, and Bristol-Myers (PR Newswire)
19.09.13	Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine (PR Newswire)
18.09.13	Clinical Trial Results, Licensing Agreements, Breakthrough Research and Development Programs - Research Report on Pfizer, Merck, Rockwell Medical, GlaxoSmithKline, and Novartis (PR Newswire)
13.09.13	GlycoMimetics' GMI-1070 Granted Orphan Drug Designation In EU - Quick Facts (RTTNews)
13.09.13	ViiV Healthcare Presents Positive Data from Phase IIIb/IV Study of Dolutegravir vs Darunavir in Treatment-Naive Adults with HIV-1 (PR Newswire)
09.09.13	Event, FDA Approval, Positive Results, Partnership, and Marketing Authorization - Research Report on Pfizer, Merck, Bristol-Myers Squibb, Lilly, and GSK (PR Newswire)
06.09.13	Critical Alerts For FedEx, AmerisourceBergen, Yelp, Pfizer, and Monsanto Released By InvestorsObserver (PR Newswire)
03.09.13	BMY, Pfizer Records Consistent Results In Sub-analysis Of Eliquis Vs. Warfarin (RTTNews)
31.08.13	Bristol-Myers,Pfizer Report Results Of Post-hoc Subanalysis From ARISTOTLE Trial (RTTNews)
29.08.13	Early Briefing and Review: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. (PR Newswire)
29.08.13	Pfizer Closes Pneumococcal Pneumonia Case Accrual For CAPiTA - Quick Facts (RTTNews)
19.08.13	MNKD To Get Financing, PTIE, DRRX Vault, BMRN On Watch (RTTNews)
13.08.13	UPDATE: Multimedia Assets Now Available: ViiV Healthcare announces U.S. approval of Tivicay® (dolutegravir) for the treatment of HIV-1 (PR Newswire)
13.08.13	ViiV Healthcare Says FDA Approves HIV Drug Tivicay (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swiss Life Hldg	687.00	-0.29 %	K V
Nestle	73.82	-0.38 %	K V
Kuehne+Nagel Int	201.50	-0.40 %	K V
Swisscom	498.80	-0.83 %	K V
Swiss Re	128.40	-0.93 %	K V
Logitech Intl	73.00	-2.43 %	K V
Roche Hldg G	247.60	-2.90 %	K V
UBS Group	26.84	-3.52 %	K V
Part Grp Hldg	1’212.00	-4.68 %	K V
ABB	49.03	-4.83 %	K V

mehr

16:05		Roche-Aktie gewinnt: Roche vermeldet Forschungsrückschlag - Mittel verfehlt primären Endpunkt
16:01		NASDAQ Composite-Handel aktuell: NASDAQ Composite zum Start mit Gewinnen
16:01		Gute Stimmung in New York: S&P 500 verbucht zum Start Zuschläge
16:01		Freundlicher Handel: Dow Jones zum Handelsstart mit Zuschlägen
16:01		Optimismus in New York: NASDAQ 100 startet im Plus
15:58		Börse London: FTSE 100 fällt am Donnerstagnachmittag
15:58		Anleger in Zürich halten sich zurück: SPI legt am Donnerstagnachmittag den Rückwärtsgang ein
15:58		Angespannte Stimmung in Europa: So entwickelt sich der Euro STOXX 50 nachmittags